Lupone G, Antonino A, Rosato A, Zenone P, Iervolino E M, Grillo M, De Palma M
Antonio Cardarelli Hospital, Napoli, Italia.
G Chir. 2012 Nov-Dec;33(11-12):395-9.
Medullary thyroid carcinoma (MTC) is a rare disease which accounts for approximately 5-9% of all thyroid cancers and originates from the calcitonin-screening parafollicular C cells. MTC can be divided into two subgroups: sporadic (75%) or inherited (25%). The majority of patients with invasive MTC have metastasis to regional lymph nodes at the time of diagnosis, as evidenced by the frequent finding of persistently elevated calcitonin levels after thyroidectomy and the high rates of recurrence in the cervical lymph nodes reported in retrospective studies.
The purpose of the study is to review our single institution's experience with MTC since 1998 and to evaluate surgical strategy, patterns of lymph node metastases and calcitonin response to compartment-oriented lymphadenectomy in patients with primary or recurrent sporadic medullary thyroid carcinoma.
A retrospective review of 26 patients treated for MTC at the "Antonio Cardarelli" Hospital referral center, in Naples, between 1998 and 2012. There were 18 female and 8 male patients, median age at presentation was 55 years, and median follow-up for survivors was 5 years. Total thyroidectomy was performed in all 26 patients; central compartment (CC) node dissection (level VI) in 12 (46%) patients; central plus lateral compartment (LC) node dissection (levels II, III, and IV) in 7 (27%) patients. 4 patients (15%) underwent reoperation for loco-regional recurrent/persistent MTC. Results. After a median post-surgical follow-up of 5 years (range 1-10 years), 63 % of patients were living disease-free, 15% were living with disease and/or persistently elevated calcitonin levels after surgery, 11% were deceased due to MTC and 11 % were lost to follow-up.
We agree with most authors advocating for a total thyroidectomy and prophylactic central neck dissection in the setting of clinically detected MTC. Lateral neck dissection may be best reserved for patients with positive preoperative imaging. Nevertheless MTC has a high rate of lymph node metastases that are sub optimally detected preoperatively in the central compartment by neck ultrasound or intra-operatively by the surgeon, and reoperation is associated with a higher rate of surgical complications. In our limited experience, patients with thyroid confined nodular pathology, without nodal disease and unknown preoperative diagnosis of MTC, underwent only total thyroidectomy with a good prognosis.
甲状腺髓样癌(MTC)是一种罕见疾病,约占所有甲状腺癌的5 - 9%,起源于分泌降钙素的滤泡旁C细胞。MTC可分为两个亚组:散发性(75%)或遗传性(25%)。大多数侵袭性MTC患者在诊断时已有区域淋巴结转移,甲状腺切除术后降钙素水平持续升高以及回顾性研究报道的颈部淋巴结高复发率均证明了这一点。
本研究的目的是回顾我们单一机构自1998年以来对MTC的治疗经验,并评估原发性或复发性散发性甲状腺髓样癌患者的手术策略、淋巴结转移模式以及降钙素对分区性淋巴结清扫的反应。
对1998年至2012年间在那不勒斯“安东尼奥·卡达雷利”医院转诊中心接受MTC治疗的26例患者进行回顾性研究。其中女性18例,男性8例,就诊时的中位年龄为55岁,存活患者的中位随访时间为5年。26例患者均接受了全甲状腺切除术;12例(46%)患者进行了中央区(CC)淋巴结清扫(Ⅵ区);7例(27%)患者进行了中央区加侧方区(LC)淋巴结清扫(Ⅱ、Ⅲ和Ⅳ区)。4例(15%)患者因局部区域复发/持续性MTC接受了再次手术。结果。术后中位随访5年(范围1 - 10年),63%的患者无病生存,15%的患者术后仍有疾病和/或降钙素水平持续升高,11%的患者因MTC死亡,11%的患者失访。
我们赞同大多数作者的观点,即在临床检测到MTC时主张进行全甲状腺切除术和预防性中央区颈部清扫。侧方颈部清扫可能最好保留给术前影像学检查阳性的患者。然而,MTC的淋巴结转移率很高,术前通过颈部超声在中央区或术中由外科医生检测均不理想,再次手术与更高的手术并发症发生率相关。根据我们有限的经验,甲状腺局限于结节性病变、无淋巴结疾病且术前MTC诊断不明的患者仅接受全甲状腺切除术,预后良好。